A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe

Completed · Phase 1

Conditions studied: Pharmacokinetics

In brief

The objective of this study is to evaluate the potential PK interaction between ABT-335, atorvastatin 80 mg and ezetimibe 10 mg when administered concurrently.

Key facts

Study ID

NCT00681525

Run by

Abbott

People needed

18

Starts

2008-04-01

Last updated by the study team

2010-10-19

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male or female subjects

You may not qualify if…

• Clinically significant diseases or disorders
• Positive screens for drug and alcohol
• Pregnant or breast-feeding females
• Any history of surgery(ies) that might interfere with the gastrointestinal motility, pH or absorption

Where it is running

• Site Reference ID/Investigator# 8087 — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.